Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q2 2026 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q3 2026 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q4 2026 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q1 2027 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q2 2027 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q3 2027 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q4 2027 | 1 | -$0.07 | -$0.07 | -$0.07 |
MAIA Biotechnology Inc last posted its earnings results on Monday, May 11th, 2026. The company reported $-0.14 earnings per share for the quarter, topping analysts' consensus estimates of $-0.18 by $0.04. The company had revenue of 0 for the quarter and had revenue of 0 for the year. MAIA Biotechnology Inc has generated $-1 earnings per share over the last year ($-0.7 diluted earnings per share) and currently has a price-to-earnings ratio of -2.02. MAIA Biotechnology Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/11/2026 | Q1 2026 | -$0.18 | -$0.14 | 0.04 | $0 | $0 |
| 03/23/2026 | Q4 2025 | -$0.13 | -$0.09 | 0.04 | $0 | $0 |
| 11/07/2025 | Q3 2025 | -$0.19 | -$0.27 | -0.08 | $0 | $0 |
| 08/11/2025 | Q2 2025 | -$0.24 | -$0.18 | 0.06 | N/A | $0 |
| 05/09/2025 | Q1 2025 | -$0.18 | -$0.16 | 0.02 | N/A | $0 |
| 03/21/2025 | Q4 2024 | -$0.20 | -$0.14 | 0.06 | N/A | $0 |
| 11/12/2024 | Q3 2024 | -$0.32 | -$0.11 | 0.21 | N/A | $0 |
| 08/09/2024 | Q2 2024 | -$0.33 | -$0.40 | -0.07 | N/A | $0 |
| 05/14/2024 | Q1 2024 | -$0.33 | -$0.46 | -0.13 | N/A | $0 |
| 03/21/2024 | Q4 2023 | -$0.35 | -$0.37 | -0.02 | N/A | $0 |
| 11/07/2023 | Q3 2023 | -$0.38 | -$0.36 | 0.02 | N/A | $0 |
| 08/08/2023 | Q2 2023 | -$0.43 | -$0.35 | 0.08 | N/A | $0 |
| 05/08/2023 | Q1 2023 | -$0.40 | -$0.37 | 0.03 | N/A | $0 |
| 03/24/2023 | Q4 2022 | -$0.41 | -$0.44 | -0.03 | N/A | $0 |
| 11/09/2022 | Q3 2022 | N/A | -$0.49 | N/A | N/A | $0 |
| 08/22/2022 | Q2 2022 | N/A | -$0.32 | N/A | N/A | $0 |
| 03/30/2022 | Q1 2022 | N/A | -$0.36 | N/A | N/A | $0 |
| 12/31/2021 | Q4 2021 | N/A | -$0.27 | N/A | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | -$0.49 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$0.32 | N/A | N/A | $0 |
In the previous quarter, MAIA Biotechnology Inc (:MAIA) reported $-0.14 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.18 by $0.04.
The conference call for MAIA Biotechnology Inc's latest earnings report can be listened to online.
The conference call transcript for MAIA Biotechnology Inc's latest earnings report can be read online.
MAIA Biotechnology Inc (:MAIA) has a recorded net income of $-22,396,172.MAIA Biotechnology Inc has generated $-0.7 earnings per share over the last four quarters.
MAIA Biotechnology Inc (:MAIA) has a price-to-earnings ratio of -2.02 and price/earnings-to-growth ratio is -1.2.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED